收藏切换
Improved Synthesis of Antihepatitis C Virus Drug Daclatasvir Dihydrochloride
收藏切换
Linfeng XING1, 2, 3, Dongshuo MENG2, 3, Jiayu JIN1, Yu LIU2, 3, *
Chinese Journal of Pharmaceuticals | 2025, 56(7) : 857 - 862
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2025, 56(7): 857-862
• Paper •
Improved Synthesis of Antihepatitis C Virus Drug Daclatasvir Dihydrochloride
Full
Linfeng XING1, 2, 3, Dongshuo MENG2, 3, Jiayu JIN1, Yu LIU2, 3, *
Affiliations
  • 1.Shanghai Desano Medicine Co., Ltd., Shanghai 201203
  • 2.Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203
  • 3.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203
Published: 2025-07-10 doi: 10.16522/j.cnki.cjph.2025.07.003
Outline
收藏切换

In the research, biphenyl(2) was used as starting material to synthesize 4,4'-bis(2-bromoacetyl)-1,1'-biphenyl(3) with high yield. Then, 4,4'-bis[N-tert-butoxycarbonyl-(2S)-pyrrolidine-2-carbonyloxymethylformyl]-1,1'-biphenyl(5) was synthesized via esterification between 3 and N-tert-butoxycarbonyl-L-proline(4). 4,4'-Bis[2-[N-tert-butoxycarbonyl-(2S)-pyrrolidine-2-yl]-1H-imidazol-5-yl]-1,1'-biphenyl(6) was prepared by ammonolysis and cyclization of 5. Compound 6 was deprotected by hydrochloric acid to give 4,4'-bis[2-[(2S)-pyrrolidine-2-yl]-1H-imidazol-5-yl]-1,1'-biphenyl tetrahydrochloride(7), which was followed by condensation with N-(methoxycarbonyl)-L-valine(8) to give the N,N'-[(1,1'-biphenyl)-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester(9), and 9 went through salt formation with HCl to provide daclatasvir dihydrochloride(1). The total mole yield was 38.5% and purity was 99.75%. The improved process has low cost and mild reaction condition, which is very suitable for industrial production.

antihepatitis C virus drug  /  nonstructural protein 5A inhibitor  /  daclatasvir dihydrochloride  /  process optimization
邢林峰, 孟冬朔, 靳家玉, 刘育. 抗丙肝药物盐酸达卡他韦的合成工艺优化. 中国医药工业杂志, 2025 , 56 (7) : 857 -862 . DOI: 10.16522/j.cnki.cjph.2025.07.003
Linfeng XING, Dongshuo MENG, Jiayu JIN, Yu LIU. Improved Synthesis of Antihepatitis C Virus Drug Daclatasvir Dihydrochloride[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (7) : 857 -862 . DOI: 10.16522/j.cnki.cjph.2025.07.003
Year 2025 volume 56 Issue 7
28
8
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.07.003
  • Receive Date:2025-02-24
  • Online Date:2026-11-18
  • Published:2025-07-10
Article Data
Affiliations
History
  • Received:2025-02-24
Affiliations
    1.Shanghai Desano Medicine Co., Ltd., Shanghai 201203
    2.Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203
    3.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.07.003
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT